Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers Health (NYSE:HIMS) Appoints Mo Elshenawy As New CTO For AI-Driven Healthcare Transformation

Hims & Hers Health (NYSE:HIMS) experienced a remarkable 97% share price increase over the past month, a move that coincided…

Hims & Hers Health (NYSE:HIMS) Appoints Mo Elshenawy As New CTO For AI-Driven Healthcare Transformation

Hims & Hers Health (NYSE:HIMS) experienced a remarkable 97% share price increase over the past month, a move that coincided…

Hims & Hers Stock Surges On Strong Q1 Results, Falls After Convertible Note Offering - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health shares have surged 17.4% this week. The company reported strong first-quarter earnings late Monday.…

Hims & Hers Announces $450M Convertible Notes Offering

An announcement from Hims & Hers Health ( ($HIMS) ) is now available. On May 8, 2025, Hims & Hers…

Hims & Hers (HIMS) Doubles Down on AI & Global Growth with $870M Boost

Hims Hers Health ($HIMS) has priced an upsized offering of $870 million in convertible senior notes due in 2030.…

Hims & Hers: The Road To Blue Chip Status (NYSE:HIMS)

Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives their best…

Hims & Hers Health Stock Is Sliding Thursday: Whats Going On? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible senior notes…

Hims & Hers shares fall on convertible notes offering By Investing.com

Hims & Hers shares fall on convertible notes offering…

Hims & Hers plans $450M convertible notes offering By Investing.com

Hims & Hers plans $450M convertible notes offering…

Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare

SAN FRANCISCO, May 08, 2025--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company", NYSE: HIMS) today announced its…

Hims & Hers Soars Again--Explosive Growth Meets Lofty Expectations (NYSE:HIMS)

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo Nordisk…

Hims & Hers names Amazon veteran as COO

Nader Kabbani, who led the technology giant’s acquisition of PillPack and the launch of Amazon Pharmacy, will take the chief…

Hims & Hers hires former Amazon exec as Q1 revenue doubles

Nader Kabbani, who spent almost 20 years at the e-commerce giant, joins the health startup as chief operations officer.…

Why Hims & Hers turned to the autonomous vehicle industry to find an AI-savvy CTO

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next…

Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Mo Elshenawy,…

Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer

SAN FRANCISCO, May 08, 2025--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the…

Wegovy Deal Makes Cofounder Of Hair Loss Pill Seller Hims A Billionaire

Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the…

Hims & Hers: 2030 Guidance Indicates Big Upside

…

Hims & Hers: 2030 Guidance Indicates Big Upside (NYSE:HIMS)

Hims & Hers managements 2030 guidance includes $6.5 billion in revenue and $1.3 billion in adjusted EBITDA. Read why HIMS…

Hims & Hers Has a Superpower in Healthcare

Hims & Hers (NYSE: HIMS) CEO Andrew Dudum isnt interested in taking insurance onto his platform, and that shows how…

Hims CEO Rides Weight-Loss Drug Boom to $1.1 Billion Fortune

A post-earnings rally in Hims & Hers Health Inc. has turned co-founder and Chief Executive Officer Andrew Dudum into a…

Hims & Hers Stock Soars 32% Since Tuesday On Strong Q1 Earnings And Robust Outlook - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health shares have surged 32.4% since Tuesdays session open. The stock is gaining following a standout first-quarter…

Surging Earnings Estimates Signal Upside for Hims & Hers Health (HIMS) Stock

Hims & Hers Health (HIMS) shares have started gaining and might continue moving higher in the near term, as indicated…

Hims & Hers: Short Squeeze Or Strong Fundamentals? (Rating Downgrade) (NYSE:HIMS)

Hims & Hers Health sees strong Q1 results and expanded EBITDA guidance, but high short interest drives May 6 rally.…

Hims & Hers Shows It’s More Than Just GLP-1 Drugs

Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after revenue more…

HIMS: Healthcare Disruptor Building A Durable Moat (Initiate With Buy) (NYSE:HIMS)

Hims & Hers reports 111% YoY sales growth & 70%+ gross margin. Discover their growth potential, risks, & why its…

Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2025 Earnings Call Transcript

Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2025 Earnings Call Transcript May 5, 2025 Hims & Hers Health, Inc. beats…

Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2025 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen. Thank you for standing by. At this time, I would like to Welcome everyone…

Hims & Hers Jumps 18.2% on Incredible 111% Revenue Growth @themotleyfool #stocks $HIMS $NVO

Hims & Hers is on fire right now.…

Hims & Hers Health First Quarter 2025 Earnings: Beats Expectations

Hims & Hers Health ( NYSE:HIMS ) First Quarter 2025 Results Key Financial Results Revenue: US$586.0m (up 111% from 1Q...…

Why Hims & Hers Health, Inc. (HIMS) Skyrocketed On Tuesday

We recently published a list of Here’s What Fueled These 10 Firms’ Surge. In this article, we are going to…

Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth

The stock of Hims & Hers Health Inc. (HIMS) fell more than 4% in after-hours trading after the telehealth company…

Hims & Hers Health, Inc. Reports Strong Q1 Earnings

Hims & Hers Health, Inc. (($HIMS)) has held its Q1 earnings call. Read on for the main highlights of the…

Whats Next For HIMS Stock After An Upbeat Q1?

Hims & Hers Health (NYSE: HIMS), a telehealth platform, recently released its Q1 financial results, revealing significant year-over-year growth. The…

Hims & Hers Health (HIMS) Stock Trades Up, Here Is Why

Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 20.2% in the afternoon session after the company reported strong…

Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped

Good news for Hims & Hers stock spooks Lilly and Novo investors.…

Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped @themotleyfool #stocks $HIMS $NVO $LLY

Good news for Hims & Hers stock spooks Lilly and Novo investors.…

2 Reasons Hims & Hers Will Break $50s - Buy Post Earnings (NYSE:HIMS)

Hims & Hers Health, Inc.s subscriber growth, Novo Nordisk partnership, and FDA pill approval could boost financials. Click for my…

Hims & Hers Health Aktie: Kursziel auf 39 USD erhöht - Ambitionierte Pläne treffen auf vorsichtige Anleger

Minneapolis (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von Piper Sandler: Aktuelle Bewertung Piper Sandler hat das Kursziel für Hims & Hers Health…

Hims surges, SolarEdge earnings beat, Rivian expands in Illinois

Yahoo Finance host Brad Smith tracks todays top moving stocks and biggest market stories in this Market Minute, including Hims &…

Hims & Hers Stock Rises on Fundamentals and Squeeze Potential

Hims & Hers stock is now giving investors another reason to consider it a buy for the coming months, as…

Whats Going On With Hims & Hers Stock Tuesday? - Hims & Hers Health (NYSE:HIMS)

Hims & Hers stock was trading lower but has since reversed and began trading higher after the company reported first-quarter…

Hims & Hers Health Faces Strategic Choice Between Semaglutide Expansion or Core Business, BofA Says

Hims & Hers Health has two strategic options to choose from post earnings, including aggressive expansion of personalized semaglutide…

Hims & Hers Health Weighs Expansion Vs. Core Focus

The company considers revamping its GLP-1 offerings or nurturing its main operations amid changing market dynamics…